Changes of protein glycosylation in the course of radiotherapy

Journal of Pharmaceutical and Biomedical Analysis

Volumn 118, Issue , 2016, Pages 380-386

  Tóth, Eszter ^a,b   Vékey, Károly ^a   Ozohanics, Olivér ^a   Jeko, Anita ^a   Dominczyk, Iwona ^c   Widlak, Piotr ^c   Drahos, László ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Glycosylation; Glycosylation pattern; Head and neck cancer; Proteomics; Radiotherapy

Indexed keywords

BETA2 GLYCOPROTEIN 1; COMPLEMENT FACTOR H; FETUIN A; HAPTOGLOBIN; KININOGEN; KININOGEN 1; OROSOMUCOID; PLASMA PROTEIN; SEROTRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEOMICS; QUANTITATIVE STUDY; RADIATION DOSE; RADIATION EXPOSURE; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; BLOOD; FEMALE; GENETICS; GLYCOSYLATION; HEAD AND NECK NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; RADIATION RESPONSE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BLOOD PROTEINS; FEMALE; GLYCOSYLATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA;

EID: 84947779251     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2015.11.010     Document Type: Article

References (33)

1. Azimzadeh O., Atkinson M.J., Tapio S. Proteomics in radiation research: present status and future perspectives. Radiat. Environ. Biophys. 2014, 53:31-38.
2. Tapio S., Hornhardt S., Gomolka M., Leszczynski D., Posch A., Thalhammer S., Atkinson M.J. Use of proteomics in radiobiological research: current state of the art. Radiat. Environ. Biophys. 2010, 49:1-4.
3. Leszczynski D. Radiation proteomics: a brief overview. Proteomics 2014, 14:481-488.
4. Guipaud O., Benderitter M. Protein biomarkers for radiation exposure: towards a proteomic approach as a new investigation tool. Ann. Ist. Super. Sanita 2009, 45:278-286.
5. Menard C., Johann D., Lowenthal M., Muanza T., Sproull M., Ross S., Gulley J., Petricoin E., Coleman C.N., Whiteley G., Liotta L., Camphausen K. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res. 2006, 66:1844-1850.
6. Marchetti F., Coleman M.A., Jones I.M., Wyrobek A.J. Candidate protein biodosimeters of human exposure to ionizing radiation. Int. J. Radiat. Biol. 2006, 82:605-639.
7. Lacombe J., Azria D., Mange A., Solassol J. Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes. Expert Rev. Proteomics 2013, 10:33-42.
8. Guipaud O., Vereycken-Holler V., Vinh J., Benderitter M. Identification of differentially expressed proteins in serums of skin-irradiated mice; characterization of potential ionising radiation biomarkers. Mol. Cell. Proteomics 2005, 4:S150.
9. Deperas-Kaminska M., Bajinskis A., Marczyk M., Polanska J., Wersall P., Lidbrink E., Ainsbury E.A., Guipaud O., Benderitter M., Haghdoost S., Wojcik A. Radiation-induced changes in levels of selected proteins in peripheral blood serum of breast cancer patients as a potential triage biodosimeter for large-scale radiological emergencies. Health Phys. 2014, 107:555-563.
10. Guipaud O. Serum and plasma proteomics and its possible use as detector and predictor of radiation diseases. Radiation Proteomics: The Effects of Ionizing and Non-Ionizing Radiation on Cells and Tissues 2013, 61-86. Springer, New York. D. Leszczynski (Ed.).
11. Yang F., Waters K.M., Webb-Robertson B.-J., Sowa M.B., von Neubeck C., Aldrich J.T., Markillie L.M., Wirgau R.M., Gritsenko M.A., Zhao R., Camp D.G., Smith R.D., Stenoien D.L. Quantitative phosphoproteomics identifies filaggrin and other targets of ionizing radiation in a human skin model. Exp. Dermatol. 2012, 21:352-357.
12. Beli P., Lukashchuk N., Wagner S.A., Weinert B.T., Olsen J.V., Baskcomb L., Mann M., Jackson S.P., Choudhary C. Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response. Mol. Cell 2012, 46:212-225.
13. Winter D., Seidler J., Ziv-Lehrman S., Shiloh Y., Lehmann W.D. Simultaneous identification and quantification of proteins by differential O-16/O-18 labeling and UPLC-MS/MS applied to mouse cerebellar phosphoproteome following irradiation. Anticancer Res. 2009, 29:4949-4958.
14. Povlsen L.K., Beli P., Wagner S.A., Poulsen S.L., Sylvestersen K.B., Poulsen J.W., Nielsen M.L., Bekker-Jensen S., Mailand N., Choudhary C. Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat. Cell Biol. 2012, 14:1089-1098.
15. Azimzadeh O., Scherthan H., Sarioglu H., Barjaktarovic Z., Conrad M., Vogt A., Calzada-Wack J., Neff F., Aubele M., Buske C., Atkinson M.J., Tapio S. Rapid proteomic remodeling of cardiac tissue caused by total body ionizing radiation. Proteomics 2011, 11:3299-3311.
16. Azimzadeh O., Sievert W., Sarioglu H., Yentrapalli R., Barjaktarovic Z., Sriharshan A., Ueffing M., Janik D., Aichler M., Atkinson M.J., Multhoff G., Tapio S. PPAR alpha: a novel radiation target in locally exposed Mus musculus heart revealed by quantitative proteomics. J. Proteome Res. 2013, 12:2700-2714.
17. Chaze T., Slomianny M.-C., Milliat F., Tarlet G., Lefebvre-Darroman T., Gourmelon P., Bey E., Benderitter M., Michalski J.-C., Guipaud O. Alteration of the serum N-glycome of mice locally exposed to high doses of ionizing radiation. Mol. Cell. Proteomics 2013, 12:283-301.
18. Lee M., Lee H.J., Seo W.D., Park K.H., Lee Y.S. Sialylation of integrin beta1 is involved in radiation-induced adhesion and migration in human colon cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:1528-1536.
19. Lee M., Lee H.J., Bae S., Lee Y.S. Protein sialylation by sialyltransferase involves radiation resistance. Mol. Cancer Res. 2008, 6:1316-1325.
20. Ma J., Han D.P., Zhang M., Chen C., Zhang B.R., Zhang Z.H., Wang X.H., Yang S.M., Guo Y.S., Okunieff P., Zhang L.R. Alteration of plasma galactose/N-acetylgalactosamine level after irradiation. Oxygen Transport to Tissue Xxxiv 2013, 147-153. Springer, New York. W.J. Welch, F. Palm, D.F. Bruley, D.K. Harrison (Eds.).
21. Rudd P.M., Dwek R.A. Glycosylation: heterogeneity and the 3D structure of proteins. Crit. Rev. Biochem. Mol. Biol. 1997, 32:1-100.
22. Arnold J.N., Wormald M.R., Sim R.B., Rudd P.M., Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 2007, 25:21-50.
23. Imperiali B., O'Connor S.E. Effect of N-linked glycosylation on glycopeptide and glycoprotein structure. Curr. Opin. Chem. Biol. 1999, 3:643-649.
24. Van den Steen P., Rudd P.M., Dwek R.A., Opdenakker G. Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 1998, 33:151-208.
25. Marino K., Bones J., Kattla J.J., Rudd P.M. A systematic approach to protein glycosylation analysis: a path through the maze. Nat. Chem. Biol. 2010, 6:713-723.
26. Geyer H., Geyer R. Strategies for analysis of glycoprotein glycosylation. Biochim. Biophys. Acta 2006, 1764:1853-1869.
27. Stadlmann J., Pabst M., Kolarich D., Kunert R., Altmann F. Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 2008, 8:2858-2871.
28. An H.J., Froehlich J.W., Lebrilla C.B. Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. Curr. Opin. Chem. Biol. 2009, 13:421-426.
29. Guipaud O., Holler V., Buard V., Tarlet G., Royer N., Vinh J., Benderitter M. Time-course analysis of mouse serum proteome changes following exposure of the skin to ionizing radiation. Proteomics 2007, 7:3992-4002.
30. Toth E., Ozohanics O., Bobaly B., Gomory A., Jeko A., Drahos L., Vekey K. HPLC enrichment/isolation of proteins for post-translational modification studies from complex mixtures. J. Pharm. Biomed. Anal. 2014, 98:393-400.
31. Ozohanics O., Turiak L., Puerta A., Vekey K., Drahos L. High-performance liquid chromatography coupled to mass spectrometry methodology for analyzing site-specific N-glycosylation patterns. J. Chromatogr. A 2012, 1259:200-212.
32. Ozohanics O., Krenyacz J., Ludanyi K., Pollreisz F., Vekey K., Drahos L. GlycoMiner: a new software tool to elucidate glycopeptide composition. Rapid Commun. Mass Spectrom. 2008, 22:3245-3254.
33. Benicky J., Sanda M., Pompach P., Wu J., Goldman R. Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease. Anal. Chem. 2014, 86:10716-10723.